Hawes D - Search Results

1

Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.

Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, Lee AS, Cote RJ. Pootrakul L, et al. Among authors: hawes d. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5987-93. doi: 10.1158/1078-0432.CCR-06-0133. Clin Cancer Res. 2006. PMID: 17062670

2

Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging.

Cote RJ, Hawes D, Chaiwun B, Beattie EJ Jr. Cote RJ, et al. Among authors: hawes d. J Surg Oncol. 1998 Dec;69(4):265-74. doi: 10.1002/(sici)1096-9098(199812)69:4<265::aid-jso12>3.0.co;2-7. J Surg Oncol. 1998. PMID: 9881945 Review.

3

Calcium-induced modification of protein conformation demonstrated by immunohistochemistry: What is the signal?

Shi SR, Cote RJ, Hawes D, Thu S, Shi Y, Young LL, Taylor CR. Shi SR, et al. Among authors: hawes d. J Histochem Cytochem. 1999 Apr;47(4):463-70. doi: 10.1177/002215549904700404. J Histochem Cytochem. 1999. PMID: 10082747

4

Occult metastasis.

Hawes D, Neville AM, Cote RJ. Hawes D, et al. Biomed Pharmacother. 2001 May;55(4):229-42. doi: 10.1016/s0753-3322(01)00052-x. Biomed Pharmacother. 2001. PMID: 11393810 Review.

5

Occult metastases in patients with breast cancer.

Hawes D, Neville AM, Cote RJ. Hawes D, et al. Ann Surg Oncol. 2001 Oct;8(9 Suppl):60S-63S. Ann Surg Oncol. 2001. PMID: 11599903

6

Detection of occult metastasis in patients with breast cancer.

Hawes D, Neville AM, Cote RJ. Hawes D, et al. Semin Surg Oncol. 2001 Jun;20(4):312-8. doi: 10.1002/ssu.1049. Semin Surg Oncol. 2001. PMID: 11747273 Review.

7

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ. Grossfeld GD, et al. Among authors: hawes d. Urology. 2002 Jan;59(1):97-102. doi: 10.1016/s0090-4295(01)01476-5. Urology. 2002. PMID: 11796289

8

Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.

Hawes D, Liu PY, Muggia FM, Wilczynski S, Cote R, Felix J, Terada K, Belt RJ, Alberts DS. Hawes D, et al. Gynecol Oncol. 2002 Oct;87(1):17-23. doi: 10.1006/gyno.2002.6755. Gynecol Oncol. 2002. PMID: 12468337 Clinical Trial.

9

Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.

Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. Xia G, et al. Among authors: hawes d. J Urol. 2006 Apr;175(4):1245-52. doi: 10.1016/S0022-5347(05)00736-6. J Urol. 2006. PMID: 16515971

10

Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.

Pagliarulo V, Hawes D, Brands FH, Groshen S, Cai J, Stein JP, Lieskovsky G, Skinner DG, Cote RJ. Pagliarulo V, et al. Among authors: hawes d. J Clin Oncol. 2006 Jun 20;24(18):2735-42. doi: 10.1200/JCO.2005.05.4767. J Clin Oncol. 2006. PMID: 16782914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters